399 related articles for article (PubMed ID: 21209348)
1. Safety and efficacy of ibutilide in cardioversion of atrial flutter and fibrillation.
Nair M; George LK; Koshy SK
J Am Board Fam Med; 2011; 24(1):86-92. PubMed ID: 21209348
[TBL] [Abstract][Full Text] [Related]
2. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
[TBL] [Abstract][Full Text] [Related]
3. Chemical cardioversion of atrial fibrillation or flutter with ibutilide in patients receiving amiodarone therapy.
Glatter K; Yang Y; Chatterjee K; Modin G; Cheng J; Kayser S; Scheinman MM
Circulation; 2001 Jan; 103(2):253-7. PubMed ID: 11208685
[TBL] [Abstract][Full Text] [Related]
4. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
[TBL] [Abstract][Full Text] [Related]
5. Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.
Patsilinakos S; Christou A; Kafkas N; Nikolaou N; Antonatos D; Katsanos S; Spanodimos S; Babalis D
Am J Cardiol; 2010 Sep; 106(5):673-6. PubMed ID: 20723644
[TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of ibutilide in children and in patients with congenital heart disease.
Hoyer AW; Balaji S
Pacing Clin Electrophysiol; 2007 Aug; 30(8):1003-8. PubMed ID: 17669084
[TBL] [Abstract][Full Text] [Related]
7. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of ibutilide versus electrical cardioversion in the conversion of atrial fibrillation and flutter to normal rhythm.
Zarkin GA; Bala MV; Calingaert B; VanderLugt JT
Am J Manag Care; 1997 Sep; 3(9):1387-94. PubMed ID: 10178487
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of ibutilide for the conversion of monomorphic atrial tachycardia.
Eidher U; Freihoff F; Kaltenbrunner W; Steinbach K
Pacing Clin Electrophysiol; 2006 Apr; 29(4):358-62. PubMed ID: 16650262
[TBL] [Abstract][Full Text] [Related]
10. Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study.
Bernard EO; Schmid ER; Schmidlin D; Scharf C; Candinas R; Germann R
Crit Care Med; 2003 Apr; 31(4):1031-4. PubMed ID: 12682468
[TBL] [Abstract][Full Text] [Related]
11. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
[TBL] [Abstract][Full Text] [Related]
12. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
Kafkas NV; Patsilinakos SP; Mertzanos GA; Papageorgiou KI; Chaveles JI; Dagadaki OK; Kelesidis KM
Int J Cardiol; 2007 Jun; 118(3):321-5. PubMed ID: 17049640
[TBL] [Abstract][Full Text] [Related]
13. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
[TBL] [Abstract][Full Text] [Related]
14. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
Naegeli B; Straumann E; Bertel O
Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
[TBL] [Abstract][Full Text] [Related]
16. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
Howard PA
Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
[TBL] [Abstract][Full Text] [Related]
17. Use of ibutilide for cardioversion of recent-onset atrial fibrillation and flutter in elderly.
Gowda RM; Khan IA; Punukollu G; Mendoza C; Wilbur SL; Vasavada BC; Sacchi TJ
Am J Ther; 2004; 11(2):95-7. PubMed ID: 14999360
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of ibutilide for cardioversion of atrial flutter and fibrillation in patients receiving amiodarone or propafenone.
Fragakis N; Papadopoulos N; Papanastasiou S; Kozirakis M; Maligkos G; Tsaritsaniotis E; Katsaris G
Pacing Clin Electrophysiol; 2005 Sep; 28(9):954-61. PubMed ID: 16176535
[TBL] [Abstract][Full Text] [Related]
19. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety.
Gowda RM; Punukollu G; Khan IA; Wilbur SL; Vasavada BC; Sacchi TJ
Am J Ther; 2003; 10(4):259-63. PubMed ID: 12845389
[TBL] [Abstract][Full Text] [Related]
20. Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter.
Steinwender C; Hönig S; Kypta A; Kammler J; Schmitt B; Leisch F; Hofmann R
Int J Cardiol; 2010 Jun; 141(3):260-5. PubMed ID: 19136164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]